Advertisement

Topics

Biofrontera AG Company Profile

10:20 EDT 26th September 2018 | BioPortfolio

Biofrontera AG is a biopharmaceutical company specializing in the development of drugs for the treatment of dermatological and inflammatory diseases. The Company has three product candidates in clinical development for four different clinical indications. The most advanced products are BF-200 ALA (Phase IIb/III) for actinic keratosis and condyloma; and BF-derm 1 (Phase II) for chronic, antihistamine-refractory urticaria. Clinical and preclinical trials have demonstrated the efficacy and excellent safety profile of both products. The third clinical candidate, BF-37, currently enters phase II development for atopic dermatitis.

Location

Hemmelrather Weg 201
Leverkusen
51377
Germany

Contact

Phone: 49 (0)214-87632-22
Fax: 49 (0)214-87632-90
Email: press@biofrontera.com


News Articles [173 Associated News Articles listed on BioPortfolio]

Biofrontera-Tochter erhebt Klage gegen DUSA Pharmaceuticals

Bad Marienberg (www.anleihencheck.de) - Biofrontera Inc. "("Biofrontera"), eine hundertprozentige Tochtergesellschaft der Biofrontera AG (ISIN DE0006046113/ WKN 604611), teilte mit, dass Biofronter...

Wochenanalyse: Biofrontera Aktie - Ist das wirklich alles?

Für die Aktie Biofrontera stehen per 13.08.2018 5,73 EUR an der Heimatbörse Xetra zu Buche. Biofrontera zählt zum Segment "Biotechnologie" Unsere Analysten haben Biofrontera nach 6 Kriterien bewert...

Biofrontera: Auf einem guten Weg

Die Analysten von SMC Research bestätigen die Kaufempfehlung für die Aktien von Biofrontera. Das Kursziel für die Papiere von Biofrontera sehen die Experten in der aktuellen Studie weiter bei 6,85 ...

Biofrontera: Neue Impulse aus Großbritannien

Die Analysten von SMC Research bestätigen die Kaufempfehlung für die Aktien von Biofrontera. Das Kursziel für die Papiere von Biofrontera sahen die Experten bisher bei 7,00 Euro. In der heutigen St...

wikifolio whispers p.m. zu Biofrontera, Advanced Micro Devices, Inc., Aumann ...

Biofrontera 0.08% ChecklisteNW (FAMIL111): Biofrontera AG ist ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung von neuen Medikamenten zur Behandlung von Haut- und Entzündungskrankh.....

DGAP-News: Biofrontera AG: Biofrontera startet eigenen Vertrieb in Großbritannien (deutsch)

Biofrontera AG: Biofrontera startet eigenen Vertrieb in Großbritannien DGAP-News: Biofrontera AG / Schlagwort(e): Produkteinführung Biofrontera AG: Biofrontera startet eigenen Vertrieb in Großbrit....

Biofrontera Aktie: Zahlungskräftige Kundschaft!

Wie Biofrontera kürzlich mitteilte, hat das Unternehmen sich das U.S. Department of Veterans Affairs als Kunden sichern können. In den gesamten USA soll Biofrontera jetzt sein Flaggschiff-Produkt A....

DGAP-Stimmrechte: Biofrontera AG (deutsch)

Biofrontera AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Biofrontera AG Biofrontera AG: Veröffentlichung gemäß § 40 Abs. 1 ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

This pilot study will try to minimize the pain during exposure to a new red light source (RhodoLED®, Biofrontera Bioscience GmbH, Leverkusen, Germany) used for PDT without compromising it...

Companies [1 Associated Companies listed on BioPortfolio]

Biofrontera AG

Biofrontera AG is a biopharmaceutical company specializing in the development of drugs for the treatment of dermatological and inflammatory diseases. The Company has three product candidates in clinic...

More Information about "Biofrontera AG" on BioPortfolio

We have published hundreds of Biofrontera AG news stories on BioPortfolio along with dozens of Biofrontera AG Clinical Trials and PubMed Articles about Biofrontera AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biofrontera AG Companies in our database. You can also find out about relevant Biofrontera AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Dermatitis
Dermatitis means an inflammation of the skin. Contact dermatitis is a term used when this inflammation is caused by contact with something in the environment. The changes of dermatitis seen in the skin take the form of eczema; hence it may sometimes be r...


Corporate Database Quicklinks



Searches Linking to this Company Record